在心力衰竭中,动态三腹反,并保留了喷射分数
Tomonari Harada1, Yogesh N V Reddy1, Hidemi Sorimachi1
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
European journal of heart failure
|September 22, 2025
概括
在心力衰竭中,与保存的喷射分数的三体反经常在运动期间恶化,导致动态右侧心力衰竭和增加不良事件风险. 运动评估对于管理这种情况至关重要.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 在心力衰竭与保存的喷射分数 (HFpEF) 中,运动期间的三回 (TR) 病理生理学仍然不太清楚.
- 了解动态TR变化对于管理HFpEF患者至关重要.
研究的目的:
- 为了研究HFpEF患者在运动期间的动态TR变化.
- 探索TR严重程度,血液动力学,心肺储备和预后之间的关系.
主要方法:
- 侵入性血液动力学运动测试,同时进行心声回声和过期气体分析.
- 评估了169名HFpEF患者,根据休息时的TR严重程度分类他们 (没有,轻度,≥中度).
主要成果:
- 在运动期间,TR严重程度经常恶化,超过一半的中度TR患者患有严重的运动TR.
- 恶化TR与右心房 (RA) 压力增加,减少RA菌株,心脏输出 (CO) 储备受损以及放大心室相互作用相关.
- 运动TR的严重程度与更高的不良事件率有关.
结论:
- 在HFpEF中,三体反与RA肌病有关,并且在运动期间经常恶化,导致动态右侧心力衰竭.
- 运动评估在临床上很重要,用于识别高风险患者.
- 进一步研究新的治疗方法,以显著的休息和运动诱导的TR是有必要的.
相关概念视频
Mitral Regurgitation I: Introduction
423
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
423
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
418
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
418
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
381
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
381
Aortic Regurgitation I: Introduction
496
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
496
Mitral Regurgitation IV: Nursing Management
311
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
311
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480


